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Antibiotic Use in a Brazilian City
F. Del Fiol ∗, S. Barberato Filho
University of Sorocaba, Sorocaba, Brazil
The indiscriminate use of antibiotics has contributed to
increase the antimicrobial resistance around the world. In
Brazil, there is no control regarding antibiotics use, once it
is possible to obtain any antibiotic without medical prescrip-
tion. The aim of the present study was to observe the quality
of the antibiotics use (prescription, orientation and use) in
a large Brazilian city. A survey (50 questions) were divided
into three parts: (1) questions about medical appointment
and prescription; (2) about patients’ pathology; (3) about
the level of information of the patient regarding antibi-
otics. 403 patients answered right before they received the
antibiotics. 3 pharmacies were included in the sample: (a)
commercial; (b) public; (c) University’s pharmacy. 28% of
the patients aged from 0 to 10 years-old, 71% of the medi-
cal appointments were performed in the free-public healthy
service and 40% of the person responsible for giving antibi-
otics to the children had less than four years of scholarity.
21% of all users have been using other drugs that could
cause drug interactions and induce therapeutic failure (51%
of patients aging 60 years or more have been using other
drugs). 40% of the patients did not complete the antibiotic
course due to economical reasons and 20% due to disappear-
ance of symptoms (fever). The majority of patients used
water to ingest the drug, but 32% used milk. 60% of the
patients did not present fever during the medical appoint-
ment. 15% did not receive any medical orientation regarding
antibiotic use. The information level of the patients regard-
ing antibiotics was 50% of correct answers, which shows
the deﬁciency of knowledge of the doctors and patients
regarding this issue. We concluded that the necessity of
educational campaigns to inform the medical staff and the
patients is very urgent in order to promote the rational use of
antibiotics and to inhibit the bacterial resistance. Supported
by FAPESP.
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Bacterial Resistance in Argolis, Greece
K. Mitrakou, I. Mitrakos, G.C. Michalopoulos, E. Xounta, G.
Mavras, M. Pavlaki, F. Rozi ∗
General Hospital of Argos, Greece, Argos, Greece
Objectives: To study the antibiotic resistance in the
microorganisms isolated from blood cultures at the Gen-
eral Hospital of Argos, Greece during the period 01/01/05
to 31/10/2007.
Methods: 791 blood cultures were studies. The iden-
tiﬁcation and the antimicrobial susceptibility tests were
performed using the analysis Bact/ALERT and the automat
system VITEK 2 compact (BIOMERIEUX).
Results: From the 791 blood cultures 661(83,56%) were
negative and 130(16,43%) were positive. CONS-coagulase
negative staphylococci were the most common isolated
bacteria [50 samples (38,46%)], followed by E. coli [25 sam-
ples (19,23%)], Brucella melitensis [21 samples (16,15%)],
Staphylococcus aureus [12 samples(9,23%)], Pseudomonas
auroginosa [7 samples (5,38%)], Klebsiella pneumoniae [3
samples (2,3%)], Enterobacter cloacae [3 samples (2,3%)],
Enterococcus faecalis [2 samples (1,53%)]. The resistance
of E. coli to Ampicillin, Amoxicylin/clavulanic, ciproﬂoxacin
and 3rd generation cephalosporins were 36%, 12%, 8% and
0% respectively. CONS and Staphylococcus aureus presented
48% and 16,66% resistance to Oxacillin respectively and
0% resistance to Vancomycin. Pseudomonas aureginosa pre-
sented 28,57% resistance to ceftazidime, aminoglycosides
and imipenem and 42,85% resistance to ciproﬂoxacin and
piperacillin. For Klebsiella pneumoniae the resistance rate
was 0% to imipenem, 33,33% to aminoglycosides, 66,66%
to ciproﬂoxacin and 3rd generarion cephalosporins. The
enterococcus faecalis strains presented 0% resistance to van-
comycin and linezolid.
Conclusions: Comparing these results to those of EARSS
(European Antimicrobial Resistance Surveillance System),
2006, was observed that the antibiotic resistance preva-
lence of E. coli was lower in this region than that of the
rest of Greece and European countries (ﬂuoroquinolones 8%
in Argolis, 14,5% in Greece, 29,2% in Germany, 28% in Spain,
13,8% in France, for cephalosporins in Argolis 0%, in Greece
6,1%, UK 7,7%, Italy 7,4%). The resistance to vancomycin of
Staphylococcus aureus 0% is similar to that seen in European
countries. Pseudomonas auroginosa and Klebsiella pneumo-
niae presented signiﬁcant resistance rate to other countries.
Greece has the higher resistance rate to imipenem, 47,6%
for pseudomonas and 32,9% for Klebsiella and also to Cef-
tazidime for Pseudomonas 34,1% but in Argolis it was 28,57%
resistance to imipenem for Pseudomonas, 0% for Klebsiella
and 28,57% resistance of Pseudomonas to ceftazidim.
doi:10.1016/j.ijid.2008.05.1054
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Prevalence of Integrons in Malaysian Isolates of Antibiotic
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Integrons are capable of scavenging transcriptionally
silent antibiotic resistance gene cassettes and converting
them into functional genes. This study characterizes the
resistance gene cassettes carried by integrons in clinical iso-
lates of multiresistant Enterobacteriaceae. Class 1 integrons
were shown to be present in 34 out of the 38 multire-
sistant strains by PCR screening for the intI1 gene. The
qacE1 & sul1 genes were present in 28 of these strains. PCR
ampliﬁcation of the 5′- and 3′-conserved segments, close to
the gene cassette crossover points showed that 23 of the
intI1-positive strains carried an integron with inserted gene
cassettes in their variable regions. The full sequences of the
inserted gene cassettes were studied by restriction mapping
and gene cassettes were classiﬁed into 8 groups. Represen-
tative gene cassettes of each group were then sequenced.
Gene cassettes were found to carry genes encoding resis-
tance to streptomycin and spectinomycin (aadA1, aadA2,
aadA5 and aadB), trimethoprim (dfrA1, dfrA15, dfr16, dfr17
